Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men
- 1 January 2008
- journal article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 158 (1), 125-129
- https://doi.org/10.1530/eje-07-0534
Abstract
Objective: Fibroblast growth factor-23 (FGF23) is a circulating factor involved in phosphate (Pi) and vitamin D metabolism. Serum FGF23 is increased at later stages of chronic kidney disease due to chronic hyperphosphatemia and decreased renal clearance. Recent studies also indicate that FGF23 may directly regulate the expression of parathyroid hormone (PTH) in vitro. Therefore, the objective of the current study was to determine the relationship between FGF23, PTH, and other biochemistries in vivo in subjects with no history of renal disease.Design: Serum biochemistries were measured in a subsample of the population-based Swedish part of the MrOS study. In total, 1000 Caucasian men aged 70–80 years were randomly selected from the population.Methods: Intact FGF23, Pi, calcium, albumin, estimated glomerular filtration rate (eGFR, calculated from cystatin C), PTH, and 25(OH)D3 were measured. Association studies were performed using linear univariate and multivariate regression analyses.Results: The median FGF23 level was 36.6 pg/ml, ranging from 0.63 to 957 pg/ml. There was a significant correlation between log FGF23 and eGFR (r=−0.21; Pr=0.13; Pβ=0.082; Pβ=−0.090; P60 ml/min. Only eGFR (β=−0.35; Pin vivo, supporting recent findings that FGF23 directly regulates PTH expression in vitro. Additionally, eGFR is associated with FGF23 in subjects with normal or mildly impaired renal function, indicating that GFR may modulate FGF23 levels independent of serum Pi.Keywords
This publication has 20 references indexed in Scilit:
- Regulation of fibroblast growth factor-23 in chronic kidney diseaseNephrology Dialysis Transplantation, 2007
- A Novel Recessive Mutation in Fibroblast Growth Factor-23 Causes Familial Tumoral CalcinosisJournal of Clinical Endocrinology & Metabolism, 2005
- Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patientsKidney International, 2005
- An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemiaHuman Molecular Genetics, 2004
- Transgenic Mice Overexpressing Human Fibroblast Growth Factor 23 (R176Q) Delineate a Putative Role for Parathyroid Hormone in Renal Phosphate Wasting DisordersEndocrinology, 2004
- Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiencyAmerican Journal of Kidney Diseases, 2004
- Transgenic Mice Expressing Fibroblast Growth Factor 23 under the Control of the α1(I) Collagen Promoter Exhibit Growth Retardation, Osteomalacia, and Disturbed Phosphate HomeostasisEndocrinology, 2004
- Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteersKidney International, 2003
- Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalaciaProceedings of the National Academy of Sciences of the United States of America, 2001
- Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23Nature Genetics, 2000